Qube Research & Technologies (QRT)’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,517,992
Closed -$26.7M 3427
2026
Q1
$26.7M Buy
1,517,992
+4,140
+0.3% +$83.1K 0.03% 710
2025
Q4
$29.9M Buy
1,513,852
+552,958
+58% +$9.93M 0.03% 716
2025
Q3
$16.8M Sell
960,894
-563,092
-37% -$8.35M 0.02% 993
2025
Q2
$21.3M Buy
1,523,986
+1,111,685
+270% +$17.9M 0.02% 843
2025
Q1
$7.68M Buy
412,301
+343,808
+502% +$5.13M 0.01% 1291
2024
Q4
$771K Buy
+68,493
New +$801K ﹤0.01% 2308
2023
Q3
Sell
-21,717
Closed -$125K 4067
2023
Q2
$125K Sell
21,717
-945
-4% -$6.11K ﹤0.01% 1907
2023
Q1
$144K Sell
22,662
-96,790
-81% -$923K ﹤0.01% 2033
2022
Q4
$1.4M Buy
119,452
+40,940
+52% +$498K 0.01% 1070
2022
Q3
$930K Buy
+78,512
New +$1.15M 0.01% 1232

Other funds holding ALHC

Qube Research & Technologies (QRT)'s ALHC Position: Q2 2026 in Review

Qube Research & Technologies (QRT) sold out of Alignment Healthcare (ALHC) in Q2 2026, closing a stake of 1,517,992 shares — an estimated $26.7M sold.

Qube Research & Technologies (QRT) first reported a position in ALHC in Q3 2022 and held it in 10 quarters. The position peaked at $29.9M in Q4 2025. 324 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

  • Qube Research & Technologies (QRT) reported no remaining Alignment Healthcare position as of Q2 2026 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 1,517,992 Alignment Healthcare shares in Q2 2026, an estimated $26.7M.
  • Qube Research & Technologies (QRT) first reported a position in Alignment Healthcare in Q3 2022 and held it in 10 quarters.
  • Qube Research & Technologies (QRT)'s Alignment Healthcare position peaked at $29.9M in Q4 2025.
  • 324 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.